The pandemic had a huge impact on where and how people seek out medical information and advice, with a large percentage of people becoming far less likely to follow a more traditional route
The 2019 Voluntary Scheme for Branded Medicines Access and Pricing (VPAS) saw the industry agreeing to make payments to the Department of Health and Social Care (DHSC).
As a successor to the 2019 Voluntary Scheme for Branded Medicines Access and Pricing is being negotiated, Leela Barham asks where rebates should go in future - that is, if rebates remain at
Daniel Kohlstaedt, managing director and founder of PurpleLeaf Strategy, explores how moving resource planning into the cloud can lead to more simplified, streamlined, and optimised brand p
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.